Goldman, Jonathan W.
Garassino, Marina Chiara
Chen, Yuanbin
Özgüroğlu, Mustafa
Dvorkin, Mikhail
Trukhin, Dmytro
Statsenko, Galina
Hotta, Katsuyuki
Ji, Jun Ho
Hochmair, Maximilian J.
Voitko, Oleksandr
Havel, Libor
Poltoratskiy, Artem
Losonczy, György
Reinmuth, Niels
Patel, Nikunj
Laud, Peter J.
Shire, Norah
Jiang, Haiyi
Paz-Ares, Luis
Funding for this research was provided by:
AstraZeneca
This article is maintained by: Elsevier
Article Title: Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study
Journal Title: Lung Cancer
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.lungcan.2020.09.003
Content Type: article
Copyright: © 2020 The Authors. Published by Elsevier B.V.